PEG Ratio
Updated 198h ago
Sector Performance
76th percentileAXON
2.39x
Sector Median
0.94x
Sector Avg
3.03x
Deep Analysis
The PEG ratio (price-to-earnings divided by expected earnings growth) of 2.39x means investors are paying $2.39 for each dollar of projected earnings growth, indicating the stock is priced above its growth rate.
This sits well above the sector median of 0.97x, placing AXON in the 77th percentile among its peers, so it is more expensive on a growth-adjusted basis than most comparable companies. The metric has been increasing over the last eight quarters: the year-over-year change is not available, but the quarter-over-quarter change is +64.8%, and the three most recent values are 2.39x, 1.45x, and 0.02x. A high and rising PEG ratio suggests that the stock's price has been outstripping its growth expectations, which can signal heightened valuation risk if growth fails to materialize. This combination of elevated level and upward trend contradicts a bullish outlook and directly supports the overall CAUTIOUS verdict, as it points to unfavorable risk versus reward versus the sector.
Frequently Asked Questions
What does the PEG Ratio tell investors about AXON?
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
How is the PEG Ratio calculated?
PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.
Who are AXON's closest peers by PEG Ratio?
The closest peers by PEG Ratio include: NUE (0.06x), VLO (0.06x), NKE (0.05x), NCLH (0.05x), MKTX (0.05x).
The Formula
P/E Ratio / EPS Growth Rate
Why It Matters
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
Master AXON's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full AXON research report →AXON
2.39x
Sector Median
0.94x
Sector Avg
3.03x
How AXON's PEG Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.